Another study linking SUMO activity with dysregulated-lipid metabolism in cancer shows that, in specific human-derived lung-cancer cells, Ubc9 upregulation mediates the conjugation of SUMO2 to the protein Fatty-Acid SyNthase (FASN)—a key enzyme for de novo synthesis of fatty acids [32]. This evidence concerns the gene FASN and lung cancer.